Farum, Denmark

Christian Weile

This inventor holds 1 USPTO granted patent and 2 published patent applications. Top assignee: Hoffmann-La Roche Inc.. Active years: 2024.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Christian Weile. Retrieved from https://idiyas.com/inventor/christian-weile

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

USPTO Granted Patents = 1 

% Patents Active = 100.0

Average Co-Inventor Count = 7.0

ph-index = 1


Company Filing History:


Years Active: 2024

Loading Chart...
1 patent (USPTO):Explore Patents

Title: Innovations by Christian Weile

Introduction

Christian Weile is an accomplished inventor based in Farum, Denmark. He has made significant contributions to the field of molecular biology, particularly in the development of antisense oligonucleotides. His work focuses on addressing the challenges posed by TDP-43 depletion in cells.

Latest Patents

Christian Weile holds a patent for "Oligonucleotides targeting RNA binding protein sites." This invention relates to antisense oligonucleotides that are complementary to conserved TDP-43 binding sites on pre-mRNA transcripts. These oligonucleotides are capable of restoring RNA binding protein function in the processing of multiple independent mRNAs in TDP-43 depleted cells. He has 1 patent to his name.

Career Highlights

Christian Weile is associated with Hoffmann-La Roche Inc., a leading global healthcare company. His work at the company has allowed him to contribute to innovative solutions in the field of RNA biology.

Collaborations

Christian has collaborated with notable colleagues, including Congwei Wang and Meiling Li, who is a prominent female scientist in the field.

Conclusion

Christian Weile's innovative work in developing antisense oligonucleotides showcases his commitment to advancing molecular biology. His contributions are vital for understanding and addressing RNA binding protein functions in cellular processes.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…